Becker's Healthcare March 7, 2024
An FDA advisory panel has unanimously recommended the agency approve a trivalent, rather than quadrivalent, flu vaccine for use next season.
The FDA’s Vaccines and Related Biological Products Advisory Committee urged manufacturers to remove the influenza B Yamagata lineage strain from next season’s flu shots during a March 5 meeting. The flu type B lineage hasn’t been detected globally since March 2020 and no longer poses...